CohBar to Announce 2019 Fourth Quarter Financial Results and Provide Business Update on March 12, 2020

Print Friendly, PDF & Email

SUMMARY OF  PLANS FOR  FUTURE CLINICAL TRIALS FOR TREATMENT FOR MITOCHONDRIA RELATED ILLNESS: Company to host conference call and webcast at 5:00 p.m. ET MENLO PARK, Calif., March 02, 2020 (GLOBE NEWSWIRE) — CohBar, Inc. ( CWBR ), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat chronic diseases and extend healthy lifespan, announced today that the company will […]